ACCESSWIRE
21 Jan 2023, 07:55 GMT+10
VANCOUVER, BC / ACCESSWIRE / January 20, 2023 / Perk Labs Inc. (CSE:PERK)(OTCQB:PKLBF)(FKT:PKLB) ('Perk' or the 'Company'), the company helping businesses transition to the digital economy, announced today that effective February 17, 2023, Andrew Bailes, a seasoned finance executive, will succeed Ms. Altamirano as Interim CFO until a permanent CFO is named. Vanessa Altamirano will step down effective February 17, 2023 to pursue another professional opportunity. Perk is currently in the process of structuring a merger with Getit Technologies Inc. ('Getit'), and as part of the process, the Company continues to review its team to optimise the integration of the two companies.
'I am thrilled to see Andrew Bailes join Perk's leadership team as we embark on this exciting journey of combining Perk and Getit's businesses. His wealth of knowledge, insights and experience will be a valuable asset as we work to optimise the integration of the two companies and pave the way for future growth,' said Jonathan Hoyles, Perk CEO.
Andrew Bailes is a Chartered Public Accountant, Principal at Hertford Advisors and has served in CFO roles since 2006. He has extensive experience in IT, Telecoms, Logistics, manufacturing and other sectors, managing finance and Legal, HR and Operational functions. Andrew did his undergraduate degree in Mathematics and Management Studies at Cambridge University in the UK and was top in his Executive MBA at Cornell and Queens. His notable achievements include:
'I look forward to leveraging my deep industry and financial experience and working closely with both Perk and Getit's talented teams to make the merger a success as the Company begins this exciting next chapter,' said Andrew Bailes.
The Company also thanked Vanessa Altamirano, who has been a valued member of the Perk team for over 5 years and played an important role in the Company's development. The Company wishes Vanessa all the best in her future endeavours.
About Perk Labs Inc.
Perk Labs Inc. (CSE:PERK) (OTCQB:PKLBF)(FKT:PKLB) is the owner of Perk Hero, the mobile commerce platform on a mission to empower business owners with the digital tools to provide their customers with dining experiences that are more engaging, convenient and rewarding. Perk Hero is growing through a unique community-driven digital franchise business that is available to entrepreneurs at an attractive start-up price.
For more information about Perk Labs, please visit www.perklabs.io. Visit Perk Hero at www.perkhero.com.
For more information on a Perk Franchise, visit www.perkfranchise.com.
For more information contact:
Jonathan Hoyles
CEO
Perk Labs Inc.
(833) 338-0299
investors@perklabs.io
Forward-Looking Statements
This press release contains forward-looking information or forward-looking statements (collectively 'forward-looking information') within the meaning of applicable securities laws. Forward-looking information is typically identified by words such as: 'may', 'believe', 'thinks', 'expect', 'exploring', 'expand', 'could', 'anticipate', 'intend', 'estimate', 'plan', 'pursue', 'potentially', 'projected', 'should', 'will' and similar expressions, or are those, which, by their nature, refer to future events. These forward-looking statements, which involve risks and uncertainties, relate to, among other things, the discussion of the Company's business strategies and its expectations concerning future operations. Although the Company considers these forward-looking statements to be reasonable based on information currently available to it, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties, and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. The Company cautions investors that any forward-looking information provided by the Company is not a guarantee of future results or performance and that actual results may differ materially from those in forward-looking statements. Undue reliance should not be placed on such forward-looking information, as there can be no assurance that the plans, intentions, or expectations upon which they are based will occur.
SOURCE: Perk Labs Inc.
Get a daily dose of Orange County Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Orange County Sun.
More InformationStephen Curry went for a game-high 35 points and contributed 11 assists to a dazzling Golden State passing display as ...
After Thursday night's massive win by the Tampa Bay Lightning, they could make history Saturday evening with a 12th consecutive ...
Washington [US], January 28 (ANI): Protests could erupt in cities across the United States after horrifying video footage was released ...
The Boston Bruins still haven't lost back-to-back games this season. Meanwhile, the Florida Panthers must halt another extended losing streak. ...
Jimmy Butler led all scorers with 29 points, including a crucial and-one with 1:29 remaining that helped lift the Miami ...
Beijing [China], January 28 (ANI): NASA Administrator Bill Nelson has warned that China could claim resource-rich regions of the moon ...
WASHINGTON D.C.: The US Justice Department has filed an antitrust complaint claiming that Google is abusing its dominance in digital ...
Public health experts have welcomed Mexico's ban on cigarette smoking in all public places, including hotels and beaches, after the ...
YONKERS, New York: After testing discovered harmful levels of heavy metals in chocolate, consumer magazine Consumer Reports has urged four ...
OUAGADOUGOU, Burkina Faso: As Burkina Faso, in western Africa, faces an Islamist insurgency, it is set to end a military ...
TOKYO, Japan: Japanese Prime minister Fumio Kishida said this week that it was "now or never" for Japan, one of ...
WASHINGTON D.C.: As part of its efforts to simplify the national COVID-19 vaccine strategy, the US Food and Drug Administration ...